BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25756591)

  • 41. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin.
    Krust B; El Khoury D; Soundaramourty C; Nondier I; Hovanessian AG
    Biochimie; 2011 Mar; 93(3):426-33. PubMed ID: 21040752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis.
    Valente P; Fassina G; Melchiori A; Masiello L; Cilli M; Vacca A; Onisto M; Santi L; Stetler-Stevenson WG; Albini A
    Int J Cancer; 1998 Jan; 75(2):246-53. PubMed ID: 9462715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
    Siveen KS; Kuttan G
    Can J Physiol Pharmacol; 2011 Oct; 89(10):691-703. PubMed ID: 21905822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype.
    Nguyen M; Lee MC; Wang JL; Tomlinson JS; Shao ZM; Alpaugh ML; Barsky SH
    Oncogene; 2000 Jul; 19(31):3449-59. PubMed ID: 10918603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells.
    Han H; Bourboulia D; Jensen-Taubman S; Isaac B; Wei B; Stetler-Stevenson WG
    Oncogene; 2014 Feb; 33(9):1198-206. PubMed ID: 23474755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR; Kim CH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TIMP-3 gene transfection suppresses invasive and metastatic capacity of human hepatocarcinoma cell line HCC-7721.
    Zhang H; Wang YS; Han G; Shi Y
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):487-91. PubMed ID: 17897911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
    Hashimoto K; Kihira Y; Matuo Y; Usui T
    J Urol; 1998 Nov; 160(5):1872-6. PubMed ID: 9783977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression.
    MacDougall JR; Bani MR; Lin Y; Muschel RJ; Kerbel RS
    Br J Cancer; 1999 May; 80(3-4):504-12. PubMed ID: 10408860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.
    Cui H; Seubert B; Stahl E; Dietz H; Reuning U; Moreno-Leon L; Ilie M; Hofman P; Nagase H; Mari B; Krüger A
    Oncogene; 2015 Jul; 34(28):3640-50. PubMed ID: 25263437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.
    Aaberg-Jessen C; Fogh L; Sørensen MD; Halle B; Brünner N; Kristensen BW
    Pathol Oncol Res; 2019 Jan; 25(1):59-69. PubMed ID: 28963609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The suppressing effect of TIMP-3 gene transfection on the invasion and metastasis of human lung carcinoma cells line].
    Niu G; Fang W; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):421-4. PubMed ID: 11244951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.
    Khokha R
    J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer.
    Miyagi M; Aoyagi K; Kato S; Shirouzu K
    Int J Clin Oncol; 2007 Feb; 12(1):17-24. PubMed ID: 17380436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver.
    Kopitz C; Gerg M; Gansbacher B; Krüger A
    Hum Gene Ther; 2008 Oct; 19(10):1039-49. PubMed ID: 18681831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colonization in lung adenocarcinoma.
    Chang YH; Chiu YJ; Cheng HC; Liu FJ; Lai WW; Chang HJ; Liao PC
    Tumour Biol; 2015 May; 36(5):3957-67. PubMed ID: 25578494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.
    Lee MS; Jung JI; Kwon SH; Lee SM; Morita K; Her S
    PLoS One; 2012; 7(4):e35710. PubMed ID: 22545131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model.
    Spurbeck WW; Ng CY; Strom TS; Vanin EF; Davidoff AM
    Blood; 2002 Nov; 100(9):3361-8. PubMed ID: 12384438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells.
    Chen X; Su Y; Fingleton B; Acuff H; Matrisian LM; Zent R; Pozzi A
    Int J Cancer; 2005 Aug; 116(1):52-61. PubMed ID: 15756690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.